BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
37 hedge funds and large institutions have $911K invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
6% more funds holding
Funds holding: 35 → 37 (+2)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
13% less capital invested
Capital invested by funds: $1.04M → $911K (-$133K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.77K |
| 2 |
ICM
Ionic Capital Management
New York
|
+$521 |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$13 |
| 4 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$13 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CTC
Central Trust Company
Jefferson City,
Missouri
|
-$29 |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$20 |
| 3 |
Morgan Stanley
New York
|
-$11 |
BTX.WS Hedge Fund Activity: Q1 2017 in Review
37 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q1 2017, worth a combined $911K — down 13% from $1.04M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BTX.WS positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $1.77K. The largest seller was Central Trust Company, cutting an estimated $29.
- 37 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q1 2017, up from 35 in Q4 2016.
- Funds reported $911K of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q1 2017, down 13% quarter-over-quarter.
- 3 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q1 2017 and 1 closed out, a net change of +2 holders.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q1 2017 was UBS Group, an estimated $1.77K added.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q1 2017 was Central Trust Company, an estimated $29 sold.
Based on aggregated 13F filings for Q1 2017.